The global market for Ventricular Tachycardia Treatment Devices was valued at US$ 3962 million in the year 2024 and is projected to reach a revised size of US$ 7360 million by 2031, growing at a CAGR of 9.3% during the forecast period.

Ventricular Tachycardia Treatment Devices Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Ventricular Tachycardia Treatment Devices competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Ventricular tachycardia (VT) treatment devices include implantable cardioverter-defibrillators (ICDs), cardiac resynchronization devices with defibrillation (CRT-D), radio-frequency ablation systems, electrophysiology (EP) catheters and external defibrillators used for acute VT management. In 2024, the global average price across these devices is approximately US$9,200 per unit, with worldwide shipments of about 430,000 units. Gross margins typically range from 45%–62%, driven by stringent reliability standards, advanced sensing algorithms, high-voltage components, biocompatible materials and regulatory compliance. The supply chain includes upstream cardiac electrodes, sensors, high-voltage capacitors, RF generators and biocompatible housings; midstream vendors integrate implantable electronics, telemetry, EP mapping software and ablation technologies; downstream customers include cardiology centers, EP labs, hospitals and emergency response networks.

The VT treatment device market is expanding as ICD/CRT-D implantation rates rise, catheter ablation becomes a preferred therapy, and hospitals invest in electrophysiology labs. Innovations in high-precision mapping, real-time sensing algorithms and remote cardiac monitoring are pushing the field toward more personalized and preventive VT management, supporting sustained market growth through 2031.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ventricular Tachycardia Treatment Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ventricular Tachycardia Treatment Devices.

The Ventricular Tachycardia Treatment Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ventricular Tachycardia Treatment Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, by Implant Type and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Ventricular Tachycardia Treatment Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Implant Type and by regions.

Scope of Ventricular Tachycardia Treatment Devices Market Report

Report Metric	Details
Report Name	Ventricular Tachycardia Treatment Devices Market
Accounted market size in year	US$ 3962 million
Forecasted market size in 2031	US$ 7360 million
CAGR	9.3%
Base Year	year
Forecasted years	2026 - 2031
Segment by Type	Implantable Cardioverter-Defibrillators (ICD) CRT-D Systems RF Ablation Systems Cryoablation Systems EP Mapping Systems
Segment by Implant Type	Fully Implantable Partially Implantable Non-implant External Devices
Segment by Mapping Resolution Type	Low-resolution Mapping High-resolution Mapping Ultra-high-density Mapping 3D Electro-anatomical Mapping
Segment by Application	Electrophysiology Labs Cardiology Departments Emergency & Trauma Centers Cardiac Surgery Units Ambulatory & Remote Monitoring
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Medtronic (ICD/CRT-D & EP Systems), Boston Scientific (ICD/CRT-D & Ablation), Abbott EP & Cardiac Rhythm Management, Biotronik (Implantable Defibrillators), MicroPort CRM, Biosense Webster (EP Mapping & Ablation), Acutus Medical, Philips EP Solutions, Zoll Medical (External Defibrillators), LivaNova (Cardiac Ablation Systems)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ventricular Tachycardia Treatment Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ventricular Tachycardia Treatment Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Ventricular Tachycardia Treatment Devices Market growing?

Ans: The Ventricular Tachycardia Treatment Devices Market witnessing a CAGR of 9.3% during the forecast period 2026-2031.

What is the Ventricular Tachycardia Treatment Devices Market size in 2031?

Ans: The Ventricular Tachycardia Treatment Devices Market size in 2031 will be US$ 7360 million.

Who are the main players in the Ventricular Tachycardia Treatment Devices Market report?

Ans: The main players in the Ventricular Tachycardia Treatment Devices Market are Medtronic (ICD/CRT-D & EP Systems), Boston Scientific (ICD/CRT-D & Ablation), Abbott EP & Cardiac Rhythm Management, Biotronik (Implantable Defibrillators), MicroPort CRM, Biosense Webster (EP Mapping & Ablation), Acutus Medical, Philips EP Solutions, Zoll Medical (External Defibrillators), LivaNova (Cardiac Ablation Systems)

What are the Application segmentation covered in the Ventricular Tachycardia Treatment Devices Market report?

Ans: The Applications covered in the Ventricular Tachycardia Treatment Devices Market report are Electrophysiology Labs, Cardiology Departments, Emergency & Trauma Centers, Cardiac Surgery Units, Ambulatory & Remote Monitoring

What are the Type segmentation covered in the Ventricular Tachycardia Treatment Devices Market report?

Ans: The Types covered in the Ventricular Tachycardia Treatment Devices Market report are Low-resolution Mapping, High-resolution Mapping, Ultra-high-density Mapping, 3D Electro-anatomical Mapping

1 Ventricular Tachycardia Treatment Devices Market Overview

1.1 Product Definition

1.2 Ventricular Tachycardia Treatment Devices by Type

1.2.1 Global Ventricular Tachycardia Treatment Devices Market Value Comparison by Type (2024 VS 2031)

1.2.2 Implantable Cardioverter-Defibrillators (ICD)

1.2.3 CRT-D Systems

1.2.4 RF Ablation Systems

1.2.5 Cryoablation Systems

1.2.6 EP Mapping Systems

1.3 Ventricular Tachycardia Treatment Devices by Implant Type

1.3.1 Global Ventricular Tachycardia Treatment Devices Market Value Comparison by Implant Type: 2024 VS 2031

1.3.2 Fully Implantable

1.3.3 Partially Implantable

1.3.4 Non-implant External Devices

1.4 Ventricular Tachycardia Treatment Devices by Mapping Resolution Type

1.4.1 Global Ventricular Tachycardia Treatment Devices Market Value Comparison by Mapping Resolution Type: 2024 VS 2031

1.4.2 Low-resolution Mapping

1.4.3 High-resolution Mapping

1.4.4 Ultra-high-density Mapping

1.4.5 3D Electro-anatomical Mapping

1.5 Ventricular Tachycardia Treatment Devices by Application

1.5.1 Global Ventricular Tachycardia Treatment Devices Market Value by Application (2024 VS 2031)

1.5.2 Electrophysiology Labs

1.5.3 Cardiology Departments

1.5.4 Emergency & Trauma Centers

1.5.5 Cardiac Surgery Units

1.5.6 Ambulatory & Remote Monitoring

1.6 Global Ventricular Tachycardia Treatment Devices Market Size Estimates and Forecasts

1.6.1 Global Ventricular Tachycardia Treatment Devices Revenue 2020-2031

1.6.2 Global Ventricular Tachycardia Treatment Devices Sales 2020-2031

1.6.3 Global Ventricular Tachycardia Treatment Devices Market Average Price (2020-2031)

1.7 Assumptions and Limitations

2 Ventricular Tachycardia Treatment Devices Market Competition by Manufacturers

2.1 Global Ventricular Tachycardia Treatment Devices Sales Market Share by Manufacturers (2020-2025)

2.2 Global Ventricular Tachycardia Treatment Devices Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Ventricular Tachycardia Treatment Devices Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Ventricular Tachycardia Treatment Devices, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Ventricular Tachycardia Treatment Devices, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Ventricular Tachycardia Treatment Devices, Product Type & Application

2.7 Global Key Manufacturers of Ventricular Tachycardia Treatment Devices, Date of Enter into This Industry

2.8 Global Ventricular Tachycardia Treatment Devices Market Competitive Situation and Trends

2.8.1 Global Ventricular Tachycardia Treatment Devices Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Ventricular Tachycardia Treatment Devices Players Market Share by Revenue

2.8.3 Global Ventricular Tachycardia Treatment Devices Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Ventricular Tachycardia Treatment Devices Market Scenario by Region

3.1 Global Ventricular Tachycardia Treatment Devices Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Ventricular Tachycardia Treatment Devices Sales by Region: 2020-2031

3.2.1 Global Ventricular Tachycardia Treatment Devices Sales by Region: 2020-2025

3.2.2 Global Ventricular Tachycardia Treatment Devices Sales by Region: 2026-2031

3.3 Global Ventricular Tachycardia Treatment Devices Revenue by Region: 2020-2031

3.3.1 Global Ventricular Tachycardia Treatment Devices Revenue by Region: 2020-2025

3.3.2 Global Ventricular Tachycardia Treatment Devices Revenue by Region: 2026-2031

3.4 North America Ventricular Tachycardia Treatment Devices Market Facts & Figures by Country

3.4.1 North America Ventricular Tachycardia Treatment Devices Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Ventricular Tachycardia Treatment Devices Sales by Country (2020-2031)

3.4.3 North America Ventricular Tachycardia Treatment Devices Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Ventricular Tachycardia Treatment Devices Market Facts & Figures by Country

3.5.1 Europe Ventricular Tachycardia Treatment Devices Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Ventricular Tachycardia Treatment Devices Sales by Country (2020-2031)

3.5.3 Europe Ventricular Tachycardia Treatment Devices Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Ventricular Tachycardia Treatment Devices Market Facts & Figures by Region

3.6.1 Asia Pacific Ventricular Tachycardia Treatment Devices Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Ventricular Tachycardia Treatment Devices Sales by Region (2020-2031)

3.6.3 Asia Pacific Ventricular Tachycardia Treatment Devices Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Ventricular Tachycardia Treatment Devices Market Facts & Figures by Country

3.7.1 Latin America Ventricular Tachycardia Treatment Devices Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Ventricular Tachycardia Treatment Devices Sales by Country (2020-2031)

3.7.3 Latin America Ventricular Tachycardia Treatment Devices Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Ventricular Tachycardia Treatment Devices Market Facts & Figures by Country

3.8.1 Middle East and Africa Ventricular Tachycardia Treatment Devices Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Ventricular Tachycardia Treatment Devices Sales by Country (2020-2031)

3.8.3 Middle East and Africa Ventricular Tachycardia Treatment Devices Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Ventricular Tachycardia Treatment Devices Sales by Type (2020-2031)

4.1.1 Global Ventricular Tachycardia Treatment Devices Sales by Type (2020-2025)

4.1.2 Global Ventricular Tachycardia Treatment Devices Sales by Type (2026-2031)

4.1.3 Global Ventricular Tachycardia Treatment Devices Sales Market Share by Type (2020-2031)

4.2 Global Ventricular Tachycardia Treatment Devices Revenue by Type (2020-2031)

4.2.1 Global Ventricular Tachycardia Treatment Devices Revenue by Type (2020-2025)

4.2.2 Global Ventricular Tachycardia Treatment Devices Revenue by Type (2026-2031)

4.2.3 Global Ventricular Tachycardia Treatment Devices Revenue Market Share by Type (2020-2031)

4.3 Global Ventricular Tachycardia Treatment Devices Price by Type (2020-2031)

5 Segment by Application

5.1 Global Ventricular Tachycardia Treatment Devices Sales by Application (2020-2031)

5.1.1 Global Ventricular Tachycardia Treatment Devices Sales by Application (2020-2025)

5.1.2 Global Ventricular Tachycardia Treatment Devices Sales by Application (2026-2031)

5.1.3 Global Ventricular Tachycardia Treatment Devices Sales Market Share by Application (2020-2031)

5.2 Global Ventricular Tachycardia Treatment Devices Revenue by Application (2020-2031)

5.2.1 Global Ventricular Tachycardia Treatment Devices Revenue by Application (2020-2025)

5.2.2 Global Ventricular Tachycardia Treatment Devices Revenue by Application (2026-2031)

5.2.3 Global Ventricular Tachycardia Treatment Devices Revenue Market Share by Application (2020-2031)

5.3 Global Ventricular Tachycardia Treatment Devices Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Medtronic (ICD/CRT-D & EP Systems)

6.1.1 Medtronic (ICD/CRT-D & EP Systems) Company Information

6.1.2 Medtronic (ICD/CRT-D & EP Systems) Description and Business Overview

6.1.3 Medtronic (ICD/CRT-D & EP Systems) Ventricular Tachycardia Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Medtronic (ICD/CRT-D & EP Systems) Ventricular Tachycardia Treatment Devices Product Portfolio

6.1.5 Medtronic (ICD/CRT-D & EP Systems) Recent Developments/Updates

6.2 Boston Scientific (ICD/CRT-D & Ablation)

6.2.1 Boston Scientific (ICD/CRT-D & Ablation) Company Information

6.2.2 Boston Scientific (ICD/CRT-D & Ablation) Description and Business Overview

6.2.3 Boston Scientific (ICD/CRT-D & Ablation) Ventricular Tachycardia Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Boston Scientific (ICD/CRT-D & Ablation) Ventricular Tachycardia Treatment Devices Product Portfolio

6.2.5 Boston Scientific (ICD/CRT-D & Ablation) Recent Developments/Updates

6.3 Abbott EP & Cardiac Rhythm Management

6.3.1 Abbott EP & Cardiac Rhythm Management Company Information

6.3.2 Abbott EP & Cardiac Rhythm Management Description and Business Overview

6.3.3 Abbott EP & Cardiac Rhythm Management Ventricular Tachycardia Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Abbott EP & Cardiac Rhythm Management Ventricular Tachycardia Treatment Devices Product Portfolio

6.3.5 Abbott EP & Cardiac Rhythm Management Recent Developments/Updates

6.4 Biotronik (Implantable Defibrillators)

6.4.1 Biotronik (Implantable Defibrillators) Company Information

6.4.2 Biotronik (Implantable Defibrillators) Description and Business Overview

6.4.3 Biotronik (Implantable Defibrillators) Ventricular Tachycardia Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Biotronik (Implantable Defibrillators) Ventricular Tachycardia Treatment Devices Product Portfolio

6.4.5 Biotronik (Implantable Defibrillators) Recent Developments/Updates

6.5 MicroPort CRM

6.5.1 MicroPort CRM Company Information

6.5.2 MicroPort CRM Description and Business Overview

6.5.3 MicroPort CRM Ventricular Tachycardia Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

6.5.4 MicroPort CRM Ventricular Tachycardia Treatment Devices Product Portfolio

6.5.5 MicroPort CRM Recent Developments/Updates

6.6 Biosense Webster (EP Mapping & Ablation)

6.6.1 Biosense Webster (EP Mapping & Ablation) Company Information

6.6.2 Biosense Webster (EP Mapping & Ablation) Description and Business Overview

6.6.3 Biosense Webster (EP Mapping & Ablation) Ventricular Tachycardia Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Biosense Webster (EP Mapping & Ablation) Ventricular Tachycardia Treatment Devices Product Portfolio

6.6.5 Biosense Webster (EP Mapping & Ablation) Recent Developments/Updates

6.7 Acutus Medical

6.7.1 Acutus Medical Company Information

6.7.2 Acutus Medical Description and Business Overview

6.7.3 Acutus Medical Ventricular Tachycardia Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Acutus Medical Ventricular Tachycardia Treatment Devices Product Portfolio

6.7.5 Acutus Medical Recent Developments/Updates

6.8 Philips EP Solutions

6.8.1 Philips EP Solutions Company Information

6.8.2 Philips EP Solutions Description and Business Overview

6.8.3 Philips EP Solutions Ventricular Tachycardia Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Philips EP Solutions Ventricular Tachycardia Treatment Devices Product Portfolio

6.8.5 Philips EP Solutions Recent Developments/Updates

6.9 Zoll Medical (External Defibrillators)

6.9.1 Zoll Medical (External Defibrillators) Company Information

6.9.2 Zoll Medical (External Defibrillators) Description and Business Overview

6.9.3 Zoll Medical (External Defibrillators) Ventricular Tachycardia Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Zoll Medical (External Defibrillators) Ventricular Tachycardia Treatment Devices Product Portfolio

6.9.5 Zoll Medical (External Defibrillators) Recent Developments/Updates

6.10 LivaNova (Cardiac Ablation Systems)

6.10.1 LivaNova (Cardiac Ablation Systems) Company Information

6.10.2 LivaNova (Cardiac Ablation Systems) Description and Business Overview

6.10.3 LivaNova (Cardiac Ablation Systems) Ventricular Tachycardia Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

6.10.4 LivaNova (Cardiac Ablation Systems) Ventricular Tachycardia Treatment Devices Product Portfolio

6.10.5 LivaNova (Cardiac Ablation Systems) Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Ventricular Tachycardia Treatment Devices Industry Chain Analysis

7.2 Ventricular Tachycardia Treatment Devices Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Ventricular Tachycardia Treatment Devices Production Mode & Process Analysis

7.4 Ventricular Tachycardia Treatment Devices Sales and Marketing

7.4.1 Ventricular Tachycardia Treatment Devices Sales Channels

7.4.2 Ventricular Tachycardia Treatment Devices Distributors

7.5 Ventricular Tachycardia Treatment Devices Customer Analysis

8 Ventricular Tachycardia Treatment Devices Market Dynamics

8.1 Ventricular Tachycardia Treatment Devices Industry Trends

8.2 Ventricular Tachycardia Treatment Devices Market Drivers

8.3 Ventricular Tachycardia Treatment Devices Market Challenges

8.4 Ventricular Tachycardia Treatment Devices Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

MicroPort CRM

Acutus Medical

Medtronic (ICD/CRT-D & EP Systems)

Boston Scientific (ICD/CRT-D & Ablation)

Abbott EP & Cardiac Rhythm Management

Biotronik (Implantable Defibrillators)

Biosense Webster (EP Mapping & Ablation)

Philips EP Solutions

Zoll Medical (External Defibrillators)

LivaNova (Cardiac Ablation Systems)

List of Tables

Table 1. Global Ventricular Tachycardia Treatment Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Ventricular Tachycardia Treatment Devices Market Value by Implant Type, (US$ Million) & (2024 VS 2031)

Table 3. Global Ventricular Tachycardia Treatment Devices Market Value by Mapping Resolution Type, (US$ Million) & (2024 VS 2031)

Table 4. Global Ventricular Tachycardia Treatment Devices Market Value by Application (2024 VS 2031) & (US$ Million)

Table 5. Global Ventricular Tachycardia Treatment Devices Market Competitive Situation by Manufacturers in 2024

Table 6. Global Ventricular Tachycardia Treatment Devices Sales (K Units) of Key Manufacturers (2020-2025)

Table 7. Global Ventricular Tachycardia Treatment Devices Sales Market Share by Manufacturers (2020-2025)

Table 8. Global Ventricular Tachycardia Treatment Devices Revenue (US$ Million) by Manufacturers (2020-2025)

Table 9. Global Ventricular Tachycardia Treatment Devices Revenue Share by Manufacturers (2020-2025)

Table 10. Global Market Ventricular Tachycardia Treatment Devices Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 11. Global Key Players of Ventricular Tachycardia Treatment Devices, Industry Ranking, 2022 VS 2023 VS 2024

Table 12. Global Key Manufacturers of Ventricular Tachycardia Treatment Devices, Manufacturing Sites & Headquarters

Table 13. Global Key Manufacturers of Ventricular Tachycardia Treatment Devices, Product Type & Application

Table 14. Global Key Manufacturers of Ventricular Tachycardia Treatment Devices, Date of Enter into This Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Ventricular Tachycardia Treatment Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ventricular Tachycardia Treatment Devices as of 2024)

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Ventricular Tachycardia Treatment Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 19. Global Ventricular Tachycardia Treatment Devices Sales by Region (2020-2025) & (K Units)

Table 20. Global Ventricular Tachycardia Treatment Devices Sales Market Share by Region (2020-2025)

Table 21. Global Ventricular Tachycardia Treatment Devices Sales by Region (2026-2031) & (K Units)

Table 22. Global Ventricular Tachycardia Treatment Devices Sales Market Share by Region (2026-2031)

Table 23. Global Ventricular Tachycardia Treatment Devices Revenue by Region (2020-2025) & (US$ Million)

Table 24. Global Ventricular Tachycardia Treatment Devices Revenue Market Share by Region (2020-2025)

Table 25. Global Ventricular Tachycardia Treatment Devices Revenue by Region (2026-2031) & (US$ Million)

Table 26. Global Ventricular Tachycardia Treatment Devices Revenue Market Share by Region (2026-2031)

Table 27. North America Ventricular Tachycardia Treatment Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 28. North America Ventricular Tachycardia Treatment Devices Sales by Country (2020-2025) & (K Units)

Table 29. North America Ventricular Tachycardia Treatment Devices Sales by Country (2026-2031) & (K Units)

Table 30. North America Ventricular Tachycardia Treatment Devices Revenue by Country (2020-2025) & (US$ Million)

Table 31. North America Ventricular Tachycardia Treatment Devices Revenue by Country (2026-2031) & (US$ Million)

Table 32. Europe Ventricular Tachycardia Treatment Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 33. Europe Ventricular Tachycardia Treatment Devices Sales by Country (2020-2025) & (K Units)

Table 34. Europe Ventricular Tachycardia Treatment Devices Sales by Country (2026-2031) & (K Units)

Table 35. Europe Ventricular Tachycardia Treatment Devices Revenue by Country (2020-2025) & (US$ Million)

Table 36. Europe Ventricular Tachycardia Treatment Devices Revenue by Country (2026-2031) & (US$ Million)

Table 37. Asia Pacific Ventricular Tachycardia Treatment Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 38. Asia Pacific Ventricular Tachycardia Treatment Devices Sales by Region (2020-2025) & (K Units)

Table 39. Asia Pacific Ventricular Tachycardia Treatment Devices Sales by Region (2026-2031) & (K Units)

Table 40. Asia Pacific Ventricular Tachycardia Treatment Devices Revenue by Region (2020-2025) & (US$ Million)

Table 41. Asia Pacific Ventricular Tachycardia Treatment Devices Revenue by Region (2026-2031) & (US$ Million)

Table 42. Latin America Ventricular Tachycardia Treatment Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Latin America Ventricular Tachycardia Treatment Devices Sales by Country (2020-2025) & (K Units)

Table 44. Latin America Ventricular Tachycardia Treatment Devices Sales by Country (2026-2031) & (K Units)

Table 45. Latin America Ventricular Tachycardia Treatment Devices Revenue by Country (2020-2025) & (US$ Million)

Table 46. Latin America Ventricular Tachycardia Treatment Devices Revenue by Country (2026-2031) & (US$ Million)

Table 47. Middle East and Africa Ventricular Tachycardia Treatment Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 48. Middle East and Africa Ventricular Tachycardia Treatment Devices Sales by Country (2020-2025) & (K Units)

Table 49. Middle East and Africa Ventricular Tachycardia Treatment Devices Sales by Country (2026-2031) & (K Units)

Table 50. Middle East and Africa Ventricular Tachycardia Treatment Devices Revenue by Country (2020-2025) & (US$ Million)

Table 51. Middle East and Africa Ventricular Tachycardia Treatment Devices Revenue by Country (2026-2031) & (US$ Million)

Table 52. Global Ventricular Tachycardia Treatment Devices Sales (K Units) by Type (2020-2025)

Table 53. Global Ventricular Tachycardia Treatment Devices Sales (K Units) by Type (2026-2031)

Table 54. Global Ventricular Tachycardia Treatment Devices Sales Market Share by Type (2020-2025)

Table 55. Global Ventricular Tachycardia Treatment Devices Sales Market Share by Type (2026-2031)

Table 56. Global Ventricular Tachycardia Treatment Devices Revenue (US$ Million) by Type (2020-2025)

Table 57. Global Ventricular Tachycardia Treatment Devices Revenue (US$ Million) by Type (2026-2031)

Table 58. Global Ventricular Tachycardia Treatment Devices Revenue Market Share by Type (2020-2025)

Table 59. Global Ventricular Tachycardia Treatment Devices Revenue Market Share by Type (2026-2031)

Table 60. Global Ventricular Tachycardia Treatment Devices Price (US$/Unit) by Type (2020-2025)

Table 61. Global Ventricular Tachycardia Treatment Devices Price (US$/Unit) by Type (2026-2031)

Table 62. Global Ventricular Tachycardia Treatment Devices Sales (K Units) by Application (2020-2025)

Table 63. Global Ventricular Tachycardia Treatment Devices Sales (K Units) by Application (2026-2031)

Table 64. Global Ventricular Tachycardia Treatment Devices Sales Market Share by Application (2020-2025)

Table 65. Global Ventricular Tachycardia Treatment Devices Sales Market Share by Application (2026-2031)

Table 66. Global Ventricular Tachycardia Treatment Devices Revenue (US$ Million) by Application (2020-2025)

Table 67. Global Ventricular Tachycardia Treatment Devices Revenue (US$ Million) by Application (2026-2031)

Table 68. Global Ventricular Tachycardia Treatment Devices Revenue Market Share by Application (2020-2025)

Table 69. Global Ventricular Tachycardia Treatment Devices Revenue Market Share by Application (2026-2031)

Table 70. Global Ventricular Tachycardia Treatment Devices Price (US$/Unit) by Application (2020-2025)

Table 71. Global Ventricular Tachycardia Treatment Devices Price (US$/Unit) by Application (2026-2031)

Table 72. Medtronic (ICD/CRT-D & EP Systems) Company Information

Table 73. Medtronic (ICD/CRT-D & EP Systems) Description and Business Overview

Table 74. Medtronic (ICD/CRT-D & EP Systems) Ventricular Tachycardia Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 75. Medtronic (ICD/CRT-D & EP Systems) Ventricular Tachycardia Treatment Devices Product

Table 76. Medtronic (ICD/CRT-D & EP Systems) Recent Developments/Updates

Table 77. Boston Scientific (ICD/CRT-D & Ablation) Company Information

Table 78. Boston Scientific (ICD/CRT-D & Ablation) Description and Business Overview

Table 79. Boston Scientific (ICD/CRT-D & Ablation) Ventricular Tachycardia Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 80. Boston Scientific (ICD/CRT-D & Ablation) Ventricular Tachycardia Treatment Devices Product

Table 81. Boston Scientific (ICD/CRT-D & Ablation) Recent Developments/Updates

Table 82. Abbott EP & Cardiac Rhythm Management Company Information

Table 83. Abbott EP & Cardiac Rhythm Management Description and Business Overview

Table 84. Abbott EP & Cardiac Rhythm Management Ventricular Tachycardia Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 85. Abbott EP & Cardiac Rhythm Management Ventricular Tachycardia Treatment Devices Product

Table 86. Abbott EP & Cardiac Rhythm Management Recent Developments/Updates

Table 87. Biotronik (Implantable Defibrillators) Company Information

Table 88. Biotronik (Implantable Defibrillators) Description and Business Overview

Table 89. Biotronik (Implantable Defibrillators) Ventricular Tachycardia Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Biotronik (Implantable Defibrillators) Ventricular Tachycardia Treatment Devices Product

Table 91. Biotronik (Implantable Defibrillators) Recent Developments/Updates

Table 92. MicroPort CRM Company Information

Table 93. MicroPort CRM Description and Business Overview

Table 94. MicroPort CRM Ventricular Tachycardia Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 95. MicroPort CRM Ventricular Tachycardia Treatment Devices Product

Table 96. MicroPort CRM Recent Developments/Updates

Table 97. Biosense Webster (EP Mapping & Ablation) Company Information

Table 98. Biosense Webster (EP Mapping & Ablation) Description and Business Overview

Table 99. Biosense Webster (EP Mapping & Ablation) Ventricular Tachycardia Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 100. Biosense Webster (EP Mapping & Ablation) Ventricular Tachycardia Treatment Devices Product

Table 101. Biosense Webster (EP Mapping & Ablation) Recent Developments/Updates

Table 102. Acutus Medical Company Information

Table 103. Acutus Medical Description and Business Overview

Table 104. Acutus Medical Ventricular Tachycardia Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 105. Acutus Medical Ventricular Tachycardia Treatment Devices Product

Table 106. Acutus Medical Recent Developments/Updates

Table 107. Philips EP Solutions Company Information

Table 108. Philips EP Solutions Description and Business Overview

Table 109. Philips EP Solutions Ventricular Tachycardia Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 110. Philips EP Solutions Ventricular Tachycardia Treatment Devices Product

Table 111. Philips EP Solutions Recent Developments/Updates

Table 112. Zoll Medical (External Defibrillators) Company Information

Table 113. Zoll Medical (External Defibrillators) Description and Business Overview

Table 114. Zoll Medical (External Defibrillators) Ventricular Tachycardia Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 115. Zoll Medical (External Defibrillators) Ventricular Tachycardia Treatment Devices Product

Table 116. Zoll Medical (External Defibrillators) Recent Developments/Updates

Table 117. LivaNova (Cardiac Ablation Systems) Company Information

Table 118. LivaNova (Cardiac Ablation Systems) Description and Business Overview

Table 119. LivaNova (Cardiac Ablation Systems) Ventricular Tachycardia Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 120. LivaNova (Cardiac Ablation Systems) Ventricular Tachycardia Treatment Devices Product

Table 121. LivaNova (Cardiac Ablation Systems) Recent Developments/Updates

Table 122. Key Raw Materials Lists

Table 123. Raw Materials Key Suppliers Lists

Table 124. Ventricular Tachycardia Treatment Devices Distributors List

Table 125. Ventricular Tachycardia Treatment Devices Customers List

Table 126. Ventricular Tachycardia Treatment Devices Market Trends

Table 127. Ventricular Tachycardia Treatment Devices Market Drivers

Table 128. Ventricular Tachycardia Treatment Devices Market Challenges

Table 129. Ventricular Tachycardia Treatment Devices Market Restraints

Table 130. Research Programs/Design for This Report

Table 131. Key Data Information from Secondary Sources

Table 132. Key Data Information from Primary Sources

Table 133. Authors List of This Report

List of Figures

Figure 1. Product Picture of Ventricular Tachycardia Treatment Devices

Figure 2. Global Ventricular Tachycardia Treatment Devices Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Ventricular Tachycardia Treatment Devices Market Share by Type: 2024 & 2031

Figure 4. Implantable Cardioverter-Defibrillators (ICD) Product Picture

Figure 5. CRT-D Systems Product Picture

Figure 6. RF Ablation Systems Product Picture

Figure 7. Cryoablation Systems Product Picture

Figure 8. EP Mapping Systems Product Picture

Figure 9. Global Ventricular Tachycardia Treatment Devices Market Value by Implant Type, (US$ Million) & (2020-2031)

Figure 10. Global Ventricular Tachycardia Treatment Devices Market Share by Implant Type: 2024 VS 2031

Figure 11. Fully Implantable Product Picture

Figure 12. Partially Implantable Product Picture

Figure 13. Non-implant External Devices Product Picture

Figure 14. Global Ventricular Tachycardia Treatment Devices Market Value by Mapping Resolution Type, (US$ Million) & (2020-2031)

Figure 15. Global Ventricular Tachycardia Treatment Devices Market Share by Mapping Resolution Type: 2024 VS 2031

Figure 16. Low-resolution Mapping Product Picture

Figure 17. High-resolution Mapping Product Picture

Figure 18. Ultra-high-density Mapping Product Picture

Figure 19. 3D Electro-anatomical Mapping Product Picture

Figure 20. Global Ventricular Tachycardia Treatment Devices Market Value by Application (2020-2031) & (US$ Million)

Figure 21. Global Ventricular Tachycardia Treatment Devices Market Share by Application: 2024 & 2031

Figure 22. Electrophysiology Labs

Figure 23. Cardiology Departments

Figure 24. Emergency & Trauma Centers

Figure 25. Cardiac Surgery Units

Figure 26. Ambulatory & Remote Monitoring

Figure 27. Global Ventricular Tachycardia Treatment Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 28. Global Ventricular Tachycardia Treatment Devices Market Size (2020-2031) & (US$ Million)

Figure 29. Global Ventricular Tachycardia Treatment Devices Sales (2020-2031) & (K Units)

Figure 30. Global Ventricular Tachycardia Treatment Devices Average Price (US$/Unit) & (2020-2031)

Figure 31. Ventricular Tachycardia Treatment Devices Report Years Considered

Figure 32. Ventricular Tachycardia Treatment Devices Sales Share by Manufacturers in 2024

Figure 33. Global Ventricular Tachycardia Treatment Devices Revenue Share by Manufacturers in 2024

Figure 34. Global 5 and 10 Largest Ventricular Tachycardia Treatment Devices Players: Market Share by Revenue in Ventricular Tachycardia Treatment Devices in 2024

Figure 35. Ventricular Tachycardia Treatment Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 36. Global Ventricular Tachycardia Treatment Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 37. North America Ventricular Tachycardia Treatment Devices Sales Market Share by Country (2020-2031)

Figure 38. North America Ventricular Tachycardia Treatment Devices Revenue Market Share by Country (2020-2031)

Figure 39. United States Ventricular Tachycardia Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Canada Ventricular Tachycardia Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Europe Ventricular Tachycardia Treatment Devices Sales Market Share by Country (2020-2031)

Figure 42. Europe Ventricular Tachycardia Treatment Devices Revenue Market Share by Country (2020-2031)

Figure 43. Germany Ventricular Tachycardia Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. France Ventricular Tachycardia Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. U.K. Ventricular Tachycardia Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Italy Ventricular Tachycardia Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Russia Ventricular Tachycardia Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Asia Pacific Ventricular Tachycardia Treatment Devices Sales Market Share by Region (2020-2031)

Figure 49. Asia Pacific Ventricular Tachycardia Treatment Devices Revenue Market Share by Region (2020-2031)

Figure 50. China Ventricular Tachycardia Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Japan Ventricular Tachycardia Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. South Korea Ventricular Tachycardia Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. India Ventricular Tachycardia Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Australia Ventricular Tachycardia Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. China Taiwan Ventricular Tachycardia Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Southeast Asia Ventricular Tachycardia Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Latin America Ventricular Tachycardia Treatment Devices Sales Market Share by Country (2020-2031)

Figure 58. Latin America Ventricular Tachycardia Treatment Devices Revenue Market Share by Country (2020-2031)

Figure 59. Mexico Ventricular Tachycardia Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 60. Brazil Ventricular Tachycardia Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 61. Argentina Ventricular Tachycardia Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 62. Colombia Ventricular Tachycardia Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 63. Middle East and Africa Ventricular Tachycardia Treatment Devices Sales Market Share by Country (2020-2031)

Figure 64. Middle East and Africa Ventricular Tachycardia Treatment Devices Revenue Market Share by Country (2020-2031)

Figure 65. Turkey Ventricular Tachycardia Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 66. Saudi Arabia Ventricular Tachycardia Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 67. UAE Ventricular Tachycardia Treatment Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 68. Global Sales Market Share of Ventricular Tachycardia Treatment Devices by Type (2020-2031)

Figure 69. Global Revenue Market Share of Ventricular Tachycardia Treatment Devices by Type (2020-2031)

Figure 70. Global Ventricular Tachycardia Treatment Devices Price (US$/Unit) by Type (2020-2031)

Figure 71. Global Sales Market Share of Ventricular Tachycardia Treatment Devices by Application (2020-2031)

Figure 72. Global Revenue Market Share of Ventricular Tachycardia Treatment Devices by Application (2020-2031)

Figure 73. Global Ventricular Tachycardia Treatment Devices Price (US$/Unit) by Application (2020-2031)

Figure 74. Ventricular Tachycardia Treatment Devices Value Chain

Figure 75. Channels of Distribution (Direct Vs Distribution)

Figure 76. Bottom-up and Top-down Approaches for This Report

Figure 77. Data Triangulation

Figure 78. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions